BP control is critical in the treatment of patients with chronic kidney disease. Recent guidelines now recommend a BP goal of <130/80 mmHg. Clinical trials using a randomized, intention-to-treat design have not established the benefits of this goal; rather, observational data and secondary or subgroup analyses drove the development of the new guidelines. A variety of observations suggest potential adverse events associate with achieving too low a BP in patients with chronic kidney disease, and ongoing randomized trials will have to establish the benefits or risks of meeting this goal. Copyright © 2010 by the American Society of Nephrology.
CITATION STYLE
Lewis, J. B. (2010). Blood pressure control in chronic kidney disease: Is less really more? Journal of the American Society of Nephrology, 21(7), 1086–1092. https://doi.org/10.1681/ASN.2010030236
Mendeley helps you to discover research relevant for your work.